New Research Division at the Leibniz Institute for Immunotherapy (LIT): “Tailored T-Cell Diversity”, headed by Prof. Carmen Gerlach
22.05.2025We’re thrilled to have Prof. Carmen Gerlach join our team. She has been dedicated to understanding diversification within CD8+ T cell responses for 20 years. Her new research division “Tailored T-Cell Diversity” works on T cell immunotherapy of cancer and inflammatory diseases.